EMEND

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug EMEND contains one active pharmaceutical ingredient (API):

1	Aprepitant UNII 1NF15YR6UY - APREPITANT
	Aprepitant is a selective high-affinity antagonist at human substance P neurokinin 1 (NK1) receptors.
	Read more about Aprepitant

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EMEND Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A04AD12	Aprepitant	A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AD Other antiemetics
Discover more medicines within A04AD12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	525503201119219
CA	Health Products and Food Branch	02298791, 02298805, 02298813
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02364367, 02364404, 06117476, 06475738, 10220501, 10518235, 10541837, 11724965, 12346436, 12554413, 16861891
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.643-04-04, 25.655-04-04, 26.008-10-04
EE	Ravimiamet	1203275, 1203286, 1203297, 1203309, 1203310, 1205345, 1315965, 1315976, 1552812, 1552823, 1708545
ES	Centro de información online de medicamentos de la AEMPS	03262006
FI	Lääkealan turvallisuus- ja kehittämiskeskus	017331, 017436, 018520
FR	Base de données publique des médicaments	60574505, 61951090, 66256064, 66824150
GB	Medicines & Healthcare Products Regulatory Agency	334566, 75296, 75303, 75309, 75310
HK	Department of Health Drug Office	52423, 52424, 52425
IE	Health Products Regulatory Authority	22443, 22472, 22508, 22517
IL	מִשְׂרַד הַבְּרִיאוּת	4969
JP	医薬品医療機器総合機構	2391008M1021, 2391008M2028, 2391008M3024
LT	Valstybinė vaistų kontrolės tarnyba	1027967, 1027968, 1027969, 1027970, 1027971, 1027972, 1027973, 1027974, 1064229, 1064230, 1079352
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	130M2003
NL	Z-Index G-Standaard, PRK	132888, 75817, 75825, 85790
NZ	Medicines and Medical Devices Safety Authority	11435
PL	Rejestru Produktów Leczniczych	100063463, 100068302, 100088322, 100309591, 100309622, 100369529
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64642001
SG	Health Sciences Authority	12369P, 12371P
TN	Direction de la Pharmacie et du Médicament	3443141
TR	İlaç ve Tıbbi Cihaz Kurumu	8699636150306
US	FDA, National Drug Code	0006-0461, 0006-0462, 0006-0464, 0006-3061, 0006-3066
ZA	Health Products Regulatory Authority	A38/5.7.2/0625, A38/5.7.2/0626, A38/5.7.2/0627